Search

Your search keyword '"Russell, Mark"' showing total 47 results

Search Constraints

Start Over You searched for: Author "Russell, Mark" Remove constraint Author: "Russell, Mark" Publication Year Range This year Remove constraint Publication Year Range: This year
47 results on '"Russell, Mark"'

Search Results

1. Patterns of Electrocardiographic Abnormalities in Children with Hypertrophic Cardiomyopathy

2. The impact of damaging epilepsy and cardiac genetic variant burden in sudden death in the young

3. STOP THE TRAIN BEFORE IT'S TOO LATE: One of the world's biggest infrastructure projects is racing ahead, despite court orders to halt construction. Conservationists fear that a train line looping around the Yucatan Peninsula is going to wreak havoc on the fragile Mexican cenotes, the jungle above and the coral reefs that border the coast

5. Abstract 4147845: Valsartan and Cardiac Remodeling in Early-Stage Hypertrophic Cardiomyopathy: The VANISH Trial Cardiac Magnetic Resonance Substudy

6. Long-Term Outcomes After Septal Reduction Therapies in Obstructive Hypertrophic Cardiomyopathy: Insights From the SHARE Registry

9. Caffeine Gum Improves Reaction Time but Reduces Composure Versus Placebo During the Extra-Time Period of Simulated Soccer Match-Play in Male Semiprofessional Players.

11. Identifying novel data-driven subgroups in congenital heart disease using multi-modal measures of brain structure

13. The test–retest reliability and validity of food photography and food diary analyses.

14. 'Supporting the Support Staff': A Narrative Review of Nutritional Opportunities to Enhance Recovery and Wellbeing in Multi-Disciplinary Soccer Performance Staff.

15. Pneumococcal vaccine uptake in patients with inflammatory arthritis: a single centre cohort study

16. OA06 Regional differences in work productivity in patients with early rheumatoid arthritis in England and Wales

17. P086 Trends in the Incidence and Management of Gout in England: A Nationwide Study using the OpenSAFELY Platform

20. OA20 Serious infections hospital admissions and mortality in patients with early inflammatory arthritis: results from the National Early Inflammatory Arthritis Audit

21. Regulation of STAT1 Signaling in Human Pancreatic β-Cells by the Lysine Deacetylase HDAC6: A New Therapeutic Opportunity in Type 1 Diabetes?

22. The Impact of Extracellular Histones and Absence of Toll-like Receptors on Cardiac Functional and Electrical Disturbances in Mouse Hearts.

23. Implementing treat-to-target urate-lowering therapy during hospitalizations for gout flares.

24. Quality of Life and Exercise Capacity in Early Stage and Subclinical Hypertrophic Cardiomyopathy: A Secondary Analysis of the VANISH Trial.

25. Occupational impacts of early inflammatory arthritis: results from the National Early Inflammatory Arthritis Audit.

27. The influence of safety warnings on the prescribing of JAK inhibitors

28. No Waning of Pneumococcal Vaccine Responses over Time in People with Inflammatory Arthritis: Findings from a Single Centre Cohort

29. Trust performance in managing inflammatory arthritis over time in England and Wales: a latent class analysis approach.

30. Incidence of Uveitis in Patients With Axial Spondylarthritis Treated With Biologics or Targeted Synthetics: A Systematic Review and Network Meta‐Analysis.

32. PREDICTORS OF ADVERSE LONG-TERM OUTCOME AFTER SEPTAL REDUCTION THERAPIES IN OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY : INSIGHTS FROM THE SHARE REGISTRY

33. Patient Characteristics and Burden of Disease in Adults with MYBPC3-Associated Hypertrophic Cardiomyopathy (MYBPC3+ HCM): Insights from the SHaRe Registry.

34. YOU ALSO SAID... UNIVERSAL TOWING MIRRORS.

35. Increased Disease Severity and Compound Sarcomere Variant Burden in Pediatric-Onset Compared to Adult-Onset MYBPC3-Associated Hypertrophic Cardiomyopathy (MYBPC3+ HCM): Insights from the SHaRe Registry.

36. British Society of Rheumatology guideline working group response to European Medicines Agency safety update on Hydroxychloroquine.

39. OpenSAFELY: The impact of COVID‐19 on azathioprine, leflunomide and methotrexate monitoring, and factors associated with change in monitoring rate.

40. Low Penetrance Sarcomere Variants Contribute to Additive Risk in Hypertrophic Cardiomyopathy.

41. Design and Rationale of the COVID Vaccine-Associated Myocarditis/Pericarditis (CAMP) Study: Short Title: Design and Rationale of the CAMP Study.

42. Impact of visualising healthcare quality performance: a systematic review.

43. Temporal and regional variation in the use of biologic and targeted synthetic DMARDs for rheumatoid arthritis: a nationwide cohort study.

44. Factors associated with biological and targeted synthetic disease-modifying antirheumatic drug initiation for rheumatoid arthritis in underserved patient groups in England and Wales, UK: a national cohort study.

45. Physical activity in the Fontan population: provider recommendations and patient actions.

46. Association between interleukin-12 p40 subunit and risk of primary Sjögren's syndrome: a Mendelian randomization study.

47. Researching COVID to enhance recovery (RECOVER) pediatric study protocol: Rationale, objectives and design.

Catalog

Books, media, physical & digital resources